MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Corticobasal degeneration (CBD)"

  • 2023 International Congress

    Neurofilament light chain, tau-PET and microglia-PET predict clinical progression in amyloid-negative corticobasal syndrome

    C. Palleis, N. Franzmeier, E. Weidinger, S. Katzdobler, N. Albert, O. Sabri, H. Barthel, R. Rupprecht, BS. Rauchmann, R. Perneczky, C. Haass, J. Levin, M. Brendel, GU. Hoeglinger (Munich, Germany)

    Objective: A head-to-head comparison of neuroimaging (tau-PET, microglia-PET, structural MRI) and plasma biomarker Neurofilament light chain (NfL) as prognostic tools for longitudinal clinical trajectories in…
  • 2023 International Congress

    Subjective cognitive complaints in patients with progressive supranuclear palsy and corticobasal syndrome

    JS. Lee, JH. Ahn, J. Youn, JW. Cho (Seoul, Republic of Korea)

    Objective: In the present study, we evaluate a prevalence of subjective cognitive complaints (SCC)in patients with progressive supranuclear palsy (PSP) as well as clinical features…
  • 2023 International Congress

    Differential effect of MAPT haplotype on survival in CBD and PSP-SCB phenotype

    A. Gharbi, I. Sghaier, I. Kacem, S. Mrabet, A. Souissi, A. Gargouri, A. Nasri, R. Gouider (Tunis, Tunisia)

    Objective: Evaluate the association of MAPT haplotype with the risk of PSP-CBS and CBD severity of tau pathology by studying the survival rate of both…
  • 2023 International Congress

    Beyond Parkinson´s disease and synucleinopathies: unexpected identification of prodromal corticobasal syndrome by the updated MDS research criteria for prodromal PD

    K. Kulcsarova, E. Feketeova, J. Ventosa, M. Maretta, A. Lackova, M. Ostrozovicova, N. Lesko, M. Bekeová, P. Christová, S. Muranska, S. Mrazova, Z. Gdovinova, M. Skorvanek (Kosice, Slovakia)

    Objective: The aim of the current study was to determine the proportion of patients, initially classified as having prodromal Parkinson’s disease (pPD), phenoconverted to manifest…
  • 2023 International Congress

    p.Gln257Profs*27 mutation in progranulin gene in a patient with corticobasal syndrome – the importance of family history

    S. Marques, A. Ferreira, M. Lopes, R. Maré, M. Rodrigues (Braga, Portugal)

    Objective: To report a case of a family with a mutation in progranulin gene manifesting as corticobasal syndrome, frontotemporal dementia and parkinson's disease. Background: Corticobasal syndrome (CBS) is mostly…
  • 2023 International Congress

    Identifying a path to improve diagnostic delay and access to care for PSP, CBS, and MSA

    M. Bruno, F. Ali, M. Dale, M. Schmidt, M. Comeau, C. Spears, J. Shurer (Honolulu, USA)

    Objective: To understand diagnosis and care experiences of patients and care partners living with progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), and multiple system atrophy…
  • 2023 International Congress

    Corticobasal Syndrome (CBS), Corticobasal Degeneration (CBD) and Progressive Supranuclear Palsy (PSP) Cohort in Central New York

    M. Iqbal, T. Chabrashvili (Syracuse, USA)

    Objective: Aims: The goal of this retrospective study was to characterize a CBS, CBD and PSP cohort and demonstrate that the Electronic Medical Record (EMR)…
  • 2022 International Congress

    Imaging Tau in Atypical Parkinsonisms: Meta-Analysis of in vivo PET Imaging Findings

    A. Mena, A. Strafella (Toronto, Canada)

    Objective: To determine the most accurate and reliable tau PET tracers for providing differential diagnosis of PSP and CBD from PD. Background: Parkinsonism is classified…
  • 2022 International Congress

    Probable Four-repeat tauopathy criteria in Corticobasal Syndrome: diagnostic accuracy, clinical features and imaging biomarkers

    J. Parmera, C. Carneiro, M. Oliveira, P. Barbosa, C. Buchpiguel, R. Nitrini, E. Barbosa, S. Brucki, A. Coutinho (São Paulo, Brazil)

    Objective: To compare the “probable four-repeat (4R)-tauopathy” criteria[1] with the clinical research(cr) criteria for corticobasal degeneration (CBD) [2] regarding diagnostic accuracy to predict a negative…
  • 2022 International Congress

    Pan India Registry for Progressive Supranuclear Palsy (PAIR-PSP)

    P. Kukkle, R. Gupta, S. Desai, S. Mehta, D. Joshi, N. Kumar, R. Kandadai, L. Sahoo, A. Mukherjee, V. Paramanandam, S. Murugan, D. Kp, S. Sundaram, R. Rajan, R. Menon, K. Shetty, P. Samson, S. Krishnan, M. Deshmukh, P. Wadia, C. Sandeep, P. Aggarwal, S. Bhowmick, H. Kumar, A. Biswas, V. Goyal, S. Seshagiri, R. Borgohain, V. Ramprasad (Bangalore, India)

    Objective: To understand Progressive Supranuclear palsy (PSP) phenotype and genotype from India. Background: Insights into PSP pathophysiology and newer clinical  phenotypes are  increasingly being recognized.…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 12
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley